The minute chromosome (Ph1) in chronic granulocytic leukemia

No abstract is available for this paper.

• Publication year

  1962

• Venue

  Blut Zeitschrift für die gesamte Blutforschung

• Publication date

  1962-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/BF01630378
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A BCR::ABL1 exon 13 variant leads to systematic underestimation of transcript level in the molecular monitoring of CML.

  2026cites this paper
• Detection of gene fusions and rearrangements in FFPE solid tumor specimens using Hi-C.

  2025cites this paper
• Pathway-Specific Therapeutic Modulation of Melanoma: Small-Molecule Inhibition of BRAF–MEK and KIT Signaling in Contemporary Precision Oncology with a Special Focus on Vemurafenib, Trametinib, and Imatinib

  2025cites this paper
• Optimizing Diagnostic Tools & Outcomes Evaluation for t (9;22)-Positive Leukemias in Pediatric Low Middle-Income Country (LMIC) Patients

  2025cites this paper
• Apport de la cytogénétique dans les hémopathies malignes

  2025cites this paper
• Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia

  2024cites this paper
• Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations

  2024cites this paper
• YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer

  2024cites this paper
• EWSR1::ATF1 Translocation: A Common Tumor Driver of Distinct Human Neoplasms

  2024cites this paper
• Multi-Omics Integration for Liver Cancer Using Regression Analysis

  2024cites this paper
• Tyrosine Kinase Inhibitors in Cancers: treatment optimization - Part I.

  2024cites this paper
• The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology

  2023cites this paper
• Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment

  2023cites this paper
• Transplantation in CML in the TKI era: who, when, and how?

  2022cites this paper
• Utility of Fluorescence In Situ Hybridization in Clinical and Research Applications.

  2022cites this paper
• A Case of Chronic Myeloid Leukemia Presenting with Osteoid Osteoma: A Diagnostic Dilemma

  2021cites this paper
• Chronic myeloid leukemia stem cells: targeting therapeutic implications

  2021cites this paper
• CRISPR/Cas9 technology abolishes the BCR/ABL1 oncogene in chronic myeloid leukemia and restores normal hematopoiesis

  2020cites this paper
• Functional heritage: the evolution of chimeric RNA into a gene

  2020cites this paper
• Pharmacogenomics and personalized medicine in the treatment of human diseases

  2020cites this paper
• Cancer Stem Cells and the Development of Cancer

  2020cites this paper
• Integrative analysis of structural variations using short-reads and linked-reads yields highly specific and sensitive predictions

  2020cites this paper
• NEAT1 and Paraspeckles in Cancer Development and Chemoresistance

  2020cites this paper
• Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure

  2020cites this paper
• Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment

  2020cites this paper
• Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia

  2019cites this paper
• Ansprechen auf Imatinib ist bei chronischer myeloischer Leukämie mit BCR-ABL1-Transkriptvariante e13a2 schlechter als bei Transkriptvariante e14a2

  2019cites this paper
• The efficacy of TKI in patients with different BCR/ABL transcript types of chronic myeloid leukemia: a systematic review and meta-analysis

  2019influential citation
• Cancer Management by Tyrosine Kinase Inhibitors: Efficacy, Limitation, and Future Strategies

  2019cites this paper
• Computational Analysis of Structural Variation in Cancer Genomes.

  2018cites this paper
• Transcriptional-Readthrough RNAs Reflect the Phenomenon of “A Gene Contains Gene(s)” or “Gene(s) within a Gene” in the Human Genome, and Thus Are Not Chimeric RNAs

  2018cites this paper
• Telomeres and Chromosomal Translocations : There's a Ligase at the End of the Translocation.

  2018cites this paper
• Chimeric RNAs and their implications in cancer.

  2018cites this paper
• FuSpot: a web-based tool for visual evaluation of fusion candidates

  2018cites this paper
• Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events

  2018cites this paper
• A review of the challenge in measuring and standardizing BCR-ABL1

  2017cites this paper
• It Is Imperative to Establish a Pellucid Definition of Chimeric RNA and to Clear Up a Lot of Confusion in the Relevant Research

  2017cites this paper
• ChimeRScope: a novel alignment-free algorithm for fusion transcript prediction using paired-end RNA-Seq data

  2017cites this paper
• Relevance of Fusion Genes in Pediatric Cancers: Toward Precision Medicine

  2017cites this paper
• UBASH3B-mediated silencing of the mitotic checkpoint: Therapeutic perspectives in cancer

  2017cites this paper
• Identification of large rearrangements in cancer genomes with barcode linked reads

  2017cites this paper
• Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents

  2017cites this paper
• Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignancies.

  2017cites this paper
• Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia

  2017cites this paper
• RNA-seq Based Transcription Characterization of Fusion Breakpoints as a Potential Estimator for Its Oncogenic Potential

  2017cites this paper
• The promise of omics-based approaches to cancer prevention.

  2016cites this paper
• A novel scoring estimator to screening for oncogenic chimeric transcripts in cancer transcriptome sequencing

  2016cites this paper
• Sequencing-based diagnostics for pediatric genetic diseases: progress and potential

  2016cites this paper
• Complex chromosomal rearrangements involving five chromosomes in chronic myelogenous leukemia: A case report.

  2016cites this paper
• Emodin Exerts an Antiapoptotic Effect on Human Chronic Myelocytic Leukemia K562 Cell Lines by Targeting the PTEN/PI3K-AKT Signaling Pathway and Deleting BCR-ABL

  2016cites this paper
• The Evolutionary Foundations of Cancer Research

  2016cites this paper
• miRNAs as Biomarkers in Chronic Myelogenous Leukemia

  2015cites this paper
• Quantitation of multiclonality in control and drug-treated tumour populations using high-throughput analysis of karyotypic heterogeneity

  2015cites this paper
• Integrated sequence and expression analysis of ovarian cancer structural variants underscores the importance of gene fusion regulation

  2015cites this paper
• Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980–2009

  2015cites this paper
• The Significance of Transcriptome Sequencing in Personalized Cancer Medicine

  2014cites this paper
• Microarray and next-generation sequencing to analyse gastric cancer.

  2014cites this paper
• Inversion-mediated gene fusions involving NAB2-STAT6 in an unusual malignant meningioma

  2013cites this paper
• Genetic instability: tipping the balance

  2013cites this paper
• JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia.

  2013cites this paper
• Why does my patient have thrombocytosis?

  2012cites this paper
• Chimeric RNAs as potential biomarkers for tumor diagnosis.

  2012cites this paper
• Re-emergence of interferon-α in the treatment of chronic myeloid leukemia

  2012cites this paper
• Gene Fusion Markup Language: a prototype for exchanging gene fusion data

  2012cites this paper
• Characterization of Chromosomal Translocations in Mouse Models of Hematological Malignancies Using Spectral Karyotyping, FISH, and Immunocytochemistry

  2012cites this paper
• Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research

  2011cites this paper
• Cancer Stem Cells: Potential Targets for Molecular Medicine

  2010cites this paper
• Five molecules we would take to a remote island.

  2010cites this paper
• Pathogenetic and clinical impact of JAK2 mutations in chronic myeloproliferative diseases

  2009cites this paper
• Molecular diagnosis of hematopoietic and lymphoid neoplasms.

  2009cites this paper
• Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease

  2008cites this paper
• Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation.

  2008cites this paper
• The role of interferon-alpha in the treatment of chronic myeloid leukemia.

  2007cites this paper
• Lapatinib in the treatment of breast cancer

  2007cites this paper
• A Review of Resistance Patterns and Phenotypic Changes in Gastrointestinal Stromal Tumors Following Imatinib Mesylate Therapy

  2007cites this paper
• Comparison of Myeloablative and Nonmyeloablative Hematopoietic Stem Cell Transplantation for Treatment of Chronic Myeloid Leukemia

  2007cites this paper
• BCR/ABL, mRNA translation and apoptosis

  2005cites this paper
• Evidence for deletion of 9q as a two‐step process in chronic myeloid leukemia

  2005cites this paper
• Nonmyeloablative stem cell transplantation for chronic myeloid leukemia.

  2004cites this paper
• Desoxyribonucleinsäurebestimmungen in den Leukocyten der normalen und leukämischen Granulopoese

  1964cites this paper
• Hematología y Oncología

  year unknowncites this paper